Spero Therapeutics (SPRO) EBIT Margin Growth (5y) (2021 - 2026)
Spero Therapeutics (SPRO) EBIT Margin Growth (5y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.07 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.92 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn |
| 4 | Moderna | 58.86 Bn | 53.72 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.88 Bn | 9.49 Bn | 668.28 Mn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - |
| 10 | Spero Therapeutics | 71.01 Mn | 20.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -265,591.00 |
| Dec 31, 2025 | 72,276.00 |
| Sep 30, 2025 | 33,063.00 |
| Jun 30, 2025 | 105,261.00 |
| Mar 31, 2025 | -12.14 Mn |
| Dec 31, 2024 | -3.81 Mn |
| Sep 30, 2024 | -1.64 Mn |
| Jun 30, 2024 | 2.02 Mn |
| Mar 31, 2024 | -991,334.00 |
| Dec 31, 2023 | 49,258.00 |
| Sep 30, 2023 | 165,426.00 |
| Jun 30, 2023 | 167,897.00 |
| Dec 31, 2022 | 153,926.00 |
| Sep 30, 2022 | 57,563.00 |
| Jun 30, 2022 | 117,162.00 |
| Mar 31, 2022 | -680,170.00 |
| Dec 31, 2021 | -1.33 Mn |
| Sep 30, 2021 | 473,264.00 |